Human amniotic membrane homogenate: A novel biomaterial-based strategy to impede migration and invasion of bladder cancer cells Abstract

Glavni sadržaj članka

Aleksandar Janev
https://orcid.org/0000-0001-9303-1903
Taja Železnik Ramuta
Urška Dragin Jerman
Hristina Obradović
Maja Čemažar
Mateja Erdani Kreft

Apstrakt

Bladder cancer ranks among the top ten most frequently diagnosed cancers globally, with approximately 25 % of diagnosed cases presenting as initially aggressive muscle-invasive tumours, marked by poor prognosis and frequent metastasis. Human amniotic membrane (hAM) is an extraembryonic membrane with anti-inflammatory, antifibrotic and antimicrobial properties, however, despite the growing number of studies, the cellular mechanisms underpinning its anticancer activity remain poorly elucidated. In our investigation, we delved into the mechanisms by which hAM homogenate influences bladder cancer and normal urothelial cells.

Downloads

Download data is not yet available.

Detalji članka

Kako citirati
Janev, A. ., Železnik Ramuta, T. ., Dragin Jerman, U. ., Obradović, H. ., Čemažar, M. ., & Erdani Kreft, M. (2024). Human amniotic membrane homogenate: A novel biomaterial-based strategy to impede migration and invasion of bladder cancer cells: Abstract. HEMIJSKA INDUSTRIJA : : ХЕМИЈСКА ИНДУСТРИЈА, 78(1S), 23. преузето од https://www.ache-pub.org.rs/index.php/HemInd/article/view/1266
Sekcija
Cancer research

Reference

Park JC, Citrin DE, Agarwal PK, Apolo AB. Multimodal management of muscle-invasive bladder cancer. Curr Probl Cancer. 2014 May-Jun;38(3):80-108. https://doi.org/10.1016/j.currproblcancer.2014.06.001

Leal-Marin S, Kern T, Hofmann N, Pogozhykh O, Framme C, Börgel M, Figueiredo C, Glasmacher B, Gryshkov O. Human Amniotic Membrane: A review on tissue engineering, application, and storage. J Biomed Mater Res B Appl Biomater. 2021 Aug;109(8):1198-1215. https://doi.org/10.1002/jbm.b.34782

Janev A, Ramuta TŽ, Jerman UD, Obradović H, Kamenšek U, Čemažar M, Kreft ME. Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK/PI3K/Akt/mTOR signalling pathway. Sci Rep. 2023 Nov 6;13(1):19227. https://doi.org/10.1038/s41598-023-46091-2.

Silini AR, Ramuta TŽ, Pires AS, Banerjee A, Dubus M, Gindraux F, Kerdjoudj H, Maciulatis J, Weidinger A, Wolbank S, Eissner G, Giebel B, Pozzobon M, Parolini O, Kreft ME. Front Bioeng Biotechnol. 2022 Oct 13;10:958669. https://doi.org/10.3389/fbioe.2022.958669.

Najčitanije od istog autora

Similar Articles

You may also start an advanced similarity search for this article.